-

Molina Healthcare Signs CEO Joe Zubretsky to New Employment Agreement

LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) announced today that its Board of Directors has entered into a contract amendment with President and Chief Executive Officer, Joe Zubretsky, designed to secure Mr. Zubretsky’s tenure through at least the end of 2027. Zubretsky, 67, joined Molina as President and Chief Executive Officer in November of 2017.

“Under Joe’s leadership we have the right strategy, great execution, and have created significant value for shareholders,” said Dale Wolf, Molina’s Chairman of the Board. “We are delighted that Joe will be at the helm for the foreseeable future to continue to do so.”

Under this contract amendment, Zubretsky was awarded a special one-time stock grant that will vest at the end of 2027 contingent upon the achievement of certain financial targets. His annual compensation remains unchanged.

About Molina Healthcare

Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. For more information about Molina Healthcare, please visit MolinaHealthcare.com.

Contacts

Investor Contact: Jeff Geyer, Jeffrey.Geyer@molinahealthcare.com, 305-317-3012
Media Contact: Caroline Zubieta, Caroline.Zubieta@molinahealthcare.com, 562-951-1588

Industry:

Molina Healthcare, Inc.

NYSE:MOH
Release Versions
English

Contacts

Investor Contact: Jeff Geyer, Jeffrey.Geyer@molinahealthcare.com, 305-317-3012
Media Contact: Caroline Zubieta, Caroline.Zubieta@molinahealthcare.com, 562-951-1588

More News From Molina Healthcare, Inc.

Molina Healthcare Announces Closing of Offering of $850 Million of 6.500% Senior Notes Due 2031

LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced the closing of its previously announced offering of $850 million aggregate principal amount of 6.500% senior notes due 2031 (the “Notes”) sold in a private offering to individuals reasonably believed to be “qualified institutional buyers” pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to certain non-U.S. persons outside the United States in rel...

Molina Healthcare Announces Pricing of $850 Million of 6.500% Senior Notes Due 2031

LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced that it priced $850 million aggregate principal amount of its 6.500% senior notes due 2031 (the “Notes”) to be sold in a private offering to individuals reasonably believed to be “qualified institutional buyers” pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to certain non-U.S. persons outside the United States in reliance on Regulation S under...

Molina Healthcare Announces Proposed Offering of $750 Million of Senior Notes Due 2031

LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced that it intends to privately offer, subject to market and other conditions, $750 million aggregate principal amount of senior notes due 2031 (the “Notes”). The Company will make the offering pursuant to an exemption under the Securities Act of 1933, as amended (the “Securities Act”). The initial purchasers will offer the Notes only to persons reasonably believed to be “qualified institutiona...
Back to Newsroom